Both in Pharmaceuticals
Bristol-Myers Squibb vs Vertex Pharmaceuticals
Over the past year BMY returned +44.7% and VRTX returned +33.5%; their daily moves had a correlation of 0.44.
BMY +44.7% VRTX +33.5%Growth of $1, one year, split-adjusted
| Metric | BMY | VRTX |
|---|---|---|
| Price | $63.88 | $527.67 |
| Market cap | $130.49B | $133.74B |
| Today | +1.62% | +0.28% |
| 1 month | −4.6% | −3.6% |
| 6 months | +9.1% | +21.8% |
| Year to date | +18.4% | +16.4% |
| 1 year | +47.2% | +38.2% |
| Revenue growth (YoY) | +5.7% | +12.5% |
| Gross margin | 71.3% | 85.3% |
| Net margin | 25.6% | 33.0% |
| P/E (TTM) | 14.1× | 30.4× |
| Price / sales | 2.7× | 10.6× |
| Net cash | -$32.05B | $7.85B |
| Dividend yield | 3.94% | — |
| Volatility (60d) | 25.5% | 26.6% |
| Short % of float | 2.1% | 1.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).